98 related articles for article (PubMed ID: 26686272)
1. Can procalcitonin monitoring reduce the length of antibiotic treatment in bloodstream infections?
Pantelidou IM; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S10-2. PubMed ID: 26686272
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.
Hochreiter M; Köhler T; Schweiger AM; Keck FS; Bein B; von Spiegel T; Schroeder S
Crit Care; 2009; 13(3):R83. PubMed ID: 19493352
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin as a biomarker of infectious diseases.
Lee H
Korean J Intern Med; 2013 May; 28(3):285-91. PubMed ID: 23682219
[TBL] [Abstract][Full Text] [Related]
4. Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study.
Stocker M; Hop WC; van Rossum AM
BMC Pediatr; 2010 Dec; 10():89. PubMed ID: 21143869
[TBL] [Abstract][Full Text] [Related]
5. Role of biomarkers in sepsis care.
Samraj RS; Zingarelli B; Wong HR
Shock; 2013 Nov; 40(5):358-65. PubMed ID: 24088989
[TBL] [Abstract][Full Text] [Related]
6. Biomarker-Guided Individualization of Antibiotic Therapy.
Aulin LBS; de Lange DW; Saleh MAA; van der Graaf PH; Völler S; van Hasselt JGC
Clin Pharmacol Ther; 2021 Aug; 110(2):346-360. PubMed ID: 33559152
[TBL] [Abstract][Full Text] [Related]
7. Using procalcitonin testing to guide treatment decisions in care homes.
Barron K
Nurs Older People; 2022 Aug; ():. PubMed ID: 36000255
[TBL] [Abstract][Full Text] [Related]
8. Which trial do we need? Optimal antibiotic duration for patients with sepsis.
Yek C; Lawandi A; Evans SR; Kadri SS
Clin Microbiol Infect; 2023 Oct; 29(10):1232-1236. PubMed ID: 37230248
[No Abstract] [Full Text] [Related]
9. Procalcitonin-guided antibiotic treatment in critically ill patients.
Hohn A; Heising B; Schütte JK; Schroeder O; Schröder S
Langenbecks Arch Surg; 2017 Feb; 402(1):1-13. PubMed ID: 27283067
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin-guided diagnosis and antibiotic stewardship revisited.
Sager R; Kutz A; Mueller B; Schuetz P
BMC Med; 2017 Jan; 15(1):15. PubMed ID: 28114931
[TBL] [Abstract][Full Text] [Related]
12. New diagnostic methods for pneumonia in the ICU.
Douglas IS
Curr Opin Infect Dis; 2016 Apr; 29(2):197-204. PubMed ID: 26859725
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial stewardship in the intensive care setting--a review and critical appraisal of the literature.
Mertz D; Brooks A; Irfan N; Sung M
Swiss Med Wkly; 2015; 145():w14220. PubMed ID: 26692020
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin: A new biomarker for the cardiologist.
Schuetz P; Daniels LB; Kulkarni P; Anker SD; Mueller B
Int J Cardiol; 2016 Nov; 223():390-397. PubMed ID: 27543716
[TBL] [Abstract][Full Text] [Related]
15. [Procalcitonin as a tool for the assessment of successful therapy of severe sepsis : An analysis using clinical routine data].
Bodmann KF; Schenker M; Heinlein W; Wilke MH
Med Klin Intensivmed Notfmed; 2018 Oct; 113(7):533-541. PubMed ID: 27376540
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin-guided therapy for the initiation of antibiotics in the ED: a systematic review.
van der Does Y; Rood PP; Haagsma JA; Patka P; van Gorp EC; Limper M
Am J Emerg Med; 2016 Jul; 34(7):1286-93. PubMed ID: 27130585
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin kinetics - prognostic and diagnostic significance in septic patients.
Lipińska-Gediga M; Mierzchała-Pasierb M; Durek G
Arch Med Sci; 2016 Feb; 12(1):112-9. PubMed ID: 26925126
[TBL] [Abstract][Full Text] [Related]
18. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.
Rhodes A; Evans LE; Alhazzani W; Levy MM; Antonelli M; Ferrer R; Kumar A; Sevransky JE; Sprung CL; Nunnally ME; Rochwerg B; Rubenfeld GD; Angus DC; Annane D; Beale RJ; Bellinghan GJ; Bernard GR; Chiche JD; Coopersmith C; De Backer DP; French CJ; Fujishima S; Gerlach H; Hidalgo JL; Hollenberg SM; Jones AE; Karnad DR; Kleinpell RM; Koh Y; Lisboa TC; Machado FR; Marini JJ; Marshall JC; Mazuski JE; McIntyre LA; McLean AS; Mehta S; Moreno RP; Myburgh J; Navalesi P; Nishida O; Osborn TM; Perner A; Plunkett CM; Ranieri M; Schorr CA; Seckel MA; Seymour CW; Shieh L; Shukri KA; Simpson SQ; Singer M; Thompson BT; Townsend SR; Van der Poll T; Vincent JL; Wiersinga WJ; Zimmerman JL; Dellinger RP
Intensive Care Med; 2017 Mar; 43(3):304-377. PubMed ID: 28101605
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic ability of procalcitonin and interleukin-6 to differentiate infectious from noninfectious systemic inflammatory response syndrome and to predict mortality.
Mat-Nor MB; Md Ralib A; Abdulah NZ; Pickering JW
J Crit Care; 2016 Jun; 33():245-51. PubMed ID: 26851139
[TBL] [Abstract][Full Text] [Related]
20. Using Procalcitonin in Septic Shock to Guide Antibacterial Therapy.
Sullivan SM; Von Rueden KT
Dimens Crit Care Nurs; 2016; 35(2):66-73. PubMed ID: 26836597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
